Brief: Maia Biotechnology Reveals New Data Showing Thio’S Potent Anticancer Activity In Aggressive Pediatric Brain Cancer
12/10/2023 14:23
Oct 12 (Reuters) - Maia Biotechnology Inc MAIA.A :
* MAIA BIOTECHNOLOGY REVEALS NEW DATA SHOWING THIO’S POTENT
ANTICANCER ACTIVITY IN AGGRESSIVE PEDIATRIC BRAIN CANCER
* MAIA BIOTECHNOLOGY INC - TREATMENT DEMONSTRATES DECREASED
CANCER
CELL PROLIFERATION AND INCREASED TUMOR SENSITIVITY TO IONIZING
RADIATION
Source text for Eikon: ID:nBw8b48Kka
Further company coverage: MAIA.A
((Reuters.Briefs@thomsonreuters.com))
Recent news on Maia Biotechnology
See all newsBrief: Maia Biotechnology Says Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr In 3l Nsclc
Brief: Maia Biotechnology - To Terminate At The Market Offering Agreement Effective May 23, 2026 - SEC Filing
Brief: Maia Biotechnology Reports Overall Survival Exceeding Two Years For Eight Patients In Ongoing Phase 2 Clinical Trial In Non-Small Cell Lung Cancer
Brief: Maia Biotechnology Inc Enters Underwriting Agreement With Konik Capital Partners - SEC Filing
MAIA Biotechnology plunges after $30 million share sale